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Legalization of hemp products in Texas has resulted in an
increase of cannabidiol (CBD) products accessible to the public.
Hemp differs from marijuana in that it must contain less than
0.3% of tetrahydrocannabinol (THC) while marijuana is
composed of predominantly THC. CBD products come in many
formulations such as creams, oils, drinks, etc. CBD products are
not manufactured under FDA standards leading to questionable
variability in the content of these products.
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The purpose of this study was to develop a method using HPLC 
to quantify and identify cannabinoids within commonly used 
CBD products amongst UT Tyler students. Additionally, the 
study aims to determine the CBD content recovered in a 
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Conclusion
The method created allowed for accurate analysis of
cannabinoids from CBD oil. The results from this method
allowed for quantification of absorption among products. Upon
quantification, discrepancies between the quantity absorbed and
quantity labeled were identified.
Methods (Continued)
Various concentrations of the dilutions were created and 
injected in the HPLC at different volumes to determine which 
condition would produce the most accurate peak. 
Panel 1 shows a standard cannabinoid solution of CBD, CBN, 
and THC at 5% injected at 10 μL. Panels 2-4 show 5% CBD 
(DF01) in Methanol: Isopropanol injected at 5 μL (Panel 2), 10 
μL (Panel 3) and 20 μL (Panel 4).
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A series of 
concentrations of 
standard cannabinoid 
solution were prepared 
(0.1%-5%), injected 
(10μL-40μL) and 
plotted to determine 
the range of 
absorbance detectable 
using the HPLC 
(Figure 3).
Using the described method, we calculated that ~70% of CBD 
was retrieved in the methanolic, as compared to the labeled 
amount, in both DF01 and DF02. However, when comparing 
the absorbance between the physiological conditions, <70% of 
DF01 was recovered while there was >70% absorbed in each 
condition in DF02.
CBD dilutions were prepared in Methanol: Isopropanol (1:1), 
Simulated Gastric Fluid (SGF), and Simulated Intestinal 
Fluid (SIF). The dilutions consisting of Gastric fluid and 
Intestinal fluid were prepared in conditions that mimic 
physiological processes. 
Results
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